IL71639A0 - Imidazoline derivatives,processes for their preparation,pharmaceutical compositions containing them and their use as histamine h2-antagonists - Google Patents

Imidazoline derivatives,processes for their preparation,pharmaceutical compositions containing them and their use as histamine h2-antagonists

Info

Publication number
IL71639A0
IL71639A0 IL71639A IL7163984A IL71639A0 IL 71639 A0 IL71639 A0 IL 71639A0 IL 71639 A IL71639 A IL 71639A IL 7163984 A IL7163984 A IL 7163984A IL 71639 A0 IL71639 A0 IL 71639A0
Authority
IL
Israel
Prior art keywords
histamine
antagonists
processes
preparation
pharmaceutical compositions
Prior art date
Application number
IL71639A
Other languages
English (en)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of IL71639A0 publication Critical patent/IL71639A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86Oxygen and sulfur atoms, e.g. thiohydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL71639A 1983-04-27 1984-04-25 Imidazoline derivatives,processes for their preparation,pharmaceutical compositions containing them and their use as histamine h2-antagonists IL71639A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838311443A GB8311443D0 (en) 1983-04-27 1983-04-27 Chemical compounds

Publications (1)

Publication Number Publication Date
IL71639A0 true IL71639A0 (en) 1984-07-31

Family

ID=10541762

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71639A IL71639A0 (en) 1983-04-27 1984-04-25 Imidazoline derivatives,processes for their preparation,pharmaceutical compositions containing them and their use as histamine h2-antagonists

Country Status (17)

Country Link
US (1) US4567176A (hu)
EP (1) EP0132914B1 (hu)
JP (1) JPS60501207A (hu)
KR (1) KR840008330A (hu)
AT (1) ATE34978T1 (hu)
DE (1) DE3471929D1 (hu)
ES (1) ES531933A0 (hu)
FI (1) FI845095A0 (hu)
GB (1) GB8311443D0 (hu)
GR (1) GR81941B (hu)
HU (1) HUT34744A (hu)
IL (1) IL71639A0 (hu)
NO (1) NO845172L (hu)
PT (1) PT78498B (hu)
WO (1) WO1984004304A1 (hu)
ZA (1) ZA843088B (hu)
ZW (1) ZW6784A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
TW221689B (hu) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
GB9611046D0 (en) * 1996-05-25 1996-07-31 Wivenhoe Techn Ltd Pharmacological compounds
US7423147B2 (en) 2004-03-31 2008-09-09 Janssen Pharmaceutical, N.V. Pyridine compounds as histamine H3 modulators
CA2653940C (en) 2006-05-30 2015-07-14 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
CA2706328C (en) 2007-11-20 2016-04-19 Janssen Pharmaceutica N.V. Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN151188B (hu) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
GR79384B (hu) * 1982-08-20 1984-10-22 Hoechst Uk Ltd

Also Published As

Publication number Publication date
ES8505668A1 (es) 1985-06-01
WO1984004304A1 (en) 1984-11-08
EP0132914B1 (en) 1988-06-08
PT78498B (en) 1986-06-02
PT78498A (en) 1984-05-01
FI845095L (fi) 1984-12-21
DE3471929D1 (de) 1988-07-14
HUT34744A (en) 1985-04-28
ATE34978T1 (de) 1988-06-15
GR81941B (hu) 1984-12-12
NO845172L (no) 1984-12-21
ZW6784A1 (en) 1985-04-17
US4567176A (en) 1986-01-28
KR840008330A (ko) 1984-12-14
EP0132914A2 (en) 1985-02-13
FI845095A0 (fi) 1984-12-21
ZA843088B (en) 1985-02-27
EP0132914A3 (en) 1985-12-27
ES531933A0 (es) 1985-06-01
GB8311443D0 (en) 1983-06-02
JPS60501207A (ja) 1985-08-01

Similar Documents

Publication Publication Date Title
IL71639A0 (en) Imidazoline derivatives,processes for their preparation,pharmaceutical compositions containing them and their use as histamine h2-antagonists
ATE78163T1 (de) Stickstoff enthaltende heterozyklische verbindungen.
ES8600254A1 (es) Un procedimiento para preparar derivados de aminopirimidinona
EP0143630A3 (en) Chemical compounds
ATE59637T1 (de) Neue basisch substituierte pyridinverbindungen, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
FI842432A0 (fi) Amidinderivat av 2-substituerad 4-fenyl-imidazoler, foerfarande foer deras framstaellning och deras farmaceutiska anvaendning.
ES8602764A1 (es) Un procedimiento para preparar derivados de tiadiazina
DE3066018D1 (en) Guanidine compounds, process for preparing them and compositions containing them
EP0140466A3 (en) Pyrimidinone derivatives, process for their preparation, and their pharmaceutical use
SE8701524D0 (sv) Nya sulfonamider och deras framstellningsforfarande
IT1210914B (it) Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico.
DE3361834D1 (en) Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them
ES8201994A1 (es) Procedimiento para la obtencion de nuevos derivados piridi- nicos de interes farmacologico